Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment

NCT02301949 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Gastrointestinal Bleeding of Unknown Origin
Gastrointestinal Vascular Malformation
Thalidomide Efficiency

Interventions

DRUG: Thalidomide
OTHER: Placebo

Sponsor

Zhizheng Ge